BellRing Brands (BRBR) 10-Q 7 May 24 2024 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Mar. 31, 2024	Apr. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	1-39093
Entity Registrant Name	BellRing Brands, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	87-3296749
Entity Address, Address Line One	2503 S. Hanley Road
Entity Address, City or Town	St. Louis
Entity Address, State or Province	MO
Entity Address, Postal Zip Code	63144
City Area Code	314
Local Phone Number	644-7600
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	BRBR
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding (in shares)		130,433,808
Entity Central Index Key	0001772016
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net Sales	$ 494.6	$ 385.6	$ 925	$ 748.3
Cost of goods sold	330.3	268.5	612.7	509.4
Gross Profit	164.3	117.1	312.3	238.9
Selling, general and administrative expenses	69.1	54.3	121.9	96
Amortization of intangible assets	4.2	4.8	26.4	9.7
Operating Profit	91	58	164	133.2
Interest expense, net	14.5	16.8	29.4	33.5
Earnings before Income Taxes	76.5	41.2	134.6	99.7
Income tax expense	19.3	10.3	33.5	24.6
Net Earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Earnings per share of Common Stock, basic (in USD per share)	$ 0.44	$ 0.23	$ 0.77	$ 0.56
Earnings per share of Common Stock, diluted (in USD per share)	$ 0.43	$ 0.23	$ 0.76	$ 0.56
Weighted Average shares of Common Stock Outstanding, basic (in shares)	131	133.4	131.1	134.1
Weighted-Averages shares of Common Stock Outstanding, diluted (in shares)	133	134.5	133	134.8

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net Earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Foreign currency translation adjustments:
Unrealized foreign currency translation adjustments	(0.4)	0.3	0.4	1.8
Other Comprehensive (Loss) Income	(0.4)	0.3	0.4	1.8
Total Comprehensive Income	$ 56.8	$ 31.2	$ 101.5	$ 76.9

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
ASSETS
Cash and cash equivalents	$ 79.3	$ 48.4
Receivables, net	229.4	168.2
Inventories	194.1	194.3
Prepaid expenses and other current assets	10.4	13.3
Total Current Assets	513.2	424.2
Property, net	8.5	8.5
Goodwill	65.9	65.9
Intangible assets, net	150.4	176.8
Deferred income taxes	12.2	4.2
Other assets	14.8	12
Total Assets	765	691.6
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Accounts payable	101.9	89
Other current liabilities	71.1	61.2
Total Current Liabilities	173	150.2
Long-term debt	832.4	856.8
Deferred income taxes	0.4	0.4
Other liabilities	6.9	7.7
Total Liabilities	1,012.7	1,015.1
Common stock	1.4	1.4
Additional paid-in capital	26.1	19.3
Accumulated deficit	(89)	(190.1)
Accumulated other comprehensive loss	(2.7)	(3.1)
Treasury stock, at cost	(183.5)	(151)
Total Stockholders’ Deficit	(247.7)	(323.5)
Total Liabilities and Stockholders’ Deficit	$ 765	$ 691.6

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows from Operating Activities:
Net Earnings	$ 101.1	$ 75.1
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	27.2	10.5
Non-cash stock-based compensation expense	10	7
Deferred income taxes	(8)	(0.9)
Other, net	1	0.2
Other changes in operating assets and liabilities:
Increase in receivables, net	(61.1)	(19.8)
Decrease (increase) in inventories	0.4	(64.5)
Decrease in prepaid expenses and other current assets	3	0.3
(Increase) decrease in other assets	(2.8)	0.9
Increase in accounts payable and other current liabilities	19.7	11.5
Net Cash Provided by Operating Activities	90.5	20.3
Cash Flows from Investing Activities:
Additions to property	(0.5)	(0.5)
Net Cash Used in Investing Activities	(0.5)	(0.5)
Cash Flows from Financing Activities:
Proceeds from issuance of long-term debt	0	115
Repayments of long-term debt	(25)	(75)
Purchases of treasury stock	(30.8)	(68.5)
Other, net	(3.4)	(2.2)
Net Cash Used in Financing Activities	(59.2)	(30.7)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.1	0.6
Net Increase (Decrease) in Cash and Cash Equivalents	30.9	(10.3)
Cash and Cash Equivalents, Beginning of Year	48.4	35.8
Cash and Cash Equivalents, End of Period	$ 79.3	$ 25.5

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Foreign Currency Translation Adjustments	Treasury Stock, Common
Stockholders' Equity, beginning of period at Sep. 30, 2022		$ 1.4	$ 7	$ (355.6)	$ (4.3)	$ (24.7)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			(2)
Non-cash stock-based compensation expense			7
Net earnings	$ 75.1			75.1
Foreign currency translation adjustments					1.8
Purchases of treasury stock						(68.8)
Stockholders' Equity, end of period at Mar. 31, 2023	(363.1)	1.4	12	(280.5)	(2.5)	(93.5)
Stockholders' Equity, beginning of period at Dec. 31, 2022		1.4	8.4	(311.4)	(2.8)	(65.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			0.1
Non-cash stock-based compensation expense			3.5
Net earnings	30.9			30.9
Foreign currency translation adjustments					0.3
Purchases of treasury stock						(27.6)
Stockholders' Equity, end of period at Mar. 31, 2023	(363.1)	1.4	12	(280.5)	(2.5)	(93.5)
Stockholders' Equity, beginning of period at Sep. 30, 2023	(323.5)	1.4	19.3	(190.1)	(3.1)	(151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			(3.2)
Non-cash stock-based compensation expense			10
Net earnings	101.1			101.1
Foreign currency translation adjustments					0.4
Purchases of treasury stock						(32.5)
Stockholders' Equity, end of period at Mar. 31, 2024	(247.7)	1.4	26.1	(89)	(2.7)	(183.5)
Stockholders' Equity, beginning of period at Dec. 31, 2023		1.4	20.6	(146.2)	(2.3)	(160.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Activity under stock and deferred compensation plans			0.1
Non-cash stock-based compensation expense			5.4
Net earnings	57.2			57.2
Foreign currency translation adjustments					(0.4)
Purchases of treasury stock						(23.1)
Stockholders' Equity, end of period at Mar. 31, 2024	$ (247.7)	$ 1.4	$ 26.1	$ (89)	$ (2.7)	$ (183.5)

Basis of Presentation (Notes)

Basis of Presentation (Notes)	6 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	BACKGROUND AND BASIS OF PRESENTATION BellRing Brands, Inc. is a consumer products holding company operating in the global convenient nutrition category and is a provider of ready-to-drink (“RTD”) protein shakes, other RTD beverages and powders. The Company has a single operating and reportable segment, with its principal products being protein-based consumer goods. The Company’s primary brands are Premier Protein and Dymatize . Unless otherwise stated or the context otherwise indicates, all references in these financial statements and notes to “BellRing,” the “Company,” “us,” “our” or “we” mean BellRing Brands, Inc. and its subsidiaries. These unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), under the rules and regulations of the United States (the “U.S.”) Securities and Exchange Commission (the “SEC”), and on a basis substantially consistent with the audited consolidated financial statements of the Company as of and for the fiscal year ended September 30, 2023. These unaudited condensed consolidated financial statements should be read in conjunction with such audited consolidated financial statements, which are included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2023, filed with the SEC on November 21, 2023. These unaudited condensed consolidated financial statements include all adjustments (consisting of normal recurring adjustments and accruals) that management considers necessary for a fair statement of the Company’s results of operations, comprehensive income, financial position, cash flows and stockholders’ equity for the interim periods presented. Interim results are not necessarily indicative of the results for any other interim period or for the entire fiscal year.

Recently Issued and Adopted Acc

Recently Issued and Adopted Accounting Standards (Notes)	6 Months Ended
	Mar. 31, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recently issued and adopted accounting standards	RECENTLY ISSUED ACCOUNTING STANDARDS The Company has considered all new accounting pronouncements and has concluded there are no new pronouncements (other than the ones described below) that had or will have a material impact on the Company’s results of operations, comprehensive income, financial position, cash flows, stockholders’ equity or related disclosures based on current information. In December 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2024 (i.e., the Company’s annual financial statements for the year ended September 30, 2026), with early adoption permitted. This ASU should be adopted prospectively; however, retrospective adoption is permitted. The Company is currently evaluating the impact of this standard. In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU is effective for fiscal years beginning after December 15, 2023 (i.e., the Company’s annual financial statements for the year ended September 30, 2025) and for interim periods within fiscal years beginning after December 15, 2024 (i.e., the Company’s interim financial statements for the three months ended December 31, 2025), with early adoption permitted. This ASU requires retrospective adoption. The Company is currently evaluating the impact of this standard.

Revenue (Notes)

Revenue (Notes)	6 Months Ended
	Mar. 31, 2024
Revenues [Abstract]
Revenue	REVENUE The following table presents net sales by product. Three Months Ended Six Months Ended 2024 2023 2024 2023 Shakes and other beverages $ 397.9 $ 299.9 $ 748.1 $ 596.9 Powders 84.1 73.8 153.8 129.9 Other 12.6 11.9 23.1 21.5 Net Sales $ 494.6 $ 385.6 $ 925.0 $ 748.3

Related Party Transactions (Not

Related Party Transactions (Notes)	6 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related party transactions	RELATED PARTY TRANSACTIONS Transactions between the Company and Post Holdings, Inc. (“Post”) are considered related party transactions as certain of the Company’s directors serve as officers or directors of Post. MSA Fees and Royalties The Company uses certain functions and services performed by Post under a master services agreement (the “MSA”). These functions and services include finance, internal audit, treasury, information technology support, insurance and tax matters, the use of office and/or data center space, payroll processing services and tax compliance services. MSA fees were $0.8 and $1.7 during the three and six months ended March 31, 2024, respectively, and $1.0 and $2.3 during the three and six months ended March 31, 2023, respectively . MSA fees were reported in “Selling, general and administrative expenses” in the Condensed Consolidated Statements of Operations. The Company licenses certain intellectual property to and from Post and its subsidiaries based upon prices governed by agreements between the Company and Post and its subsidiaries, consistent with prices of similar arm's-length transactions . During both the three and six months ended March 31, 2024 and 2023, royalties paid to and received from Post and its subsidiaries were immaterial. Co-Packing Agreement On September 30, 2022, Premier Nutrition Company, LLC (“Premier Nutrition”) , a subsidiary of the Company, entered into a co-packing agreement with Comet Processing, Inc. (“Comet”), a wholly-owned subsidiary of Post (the “Co-Packing Agreement”). Under the Co-Packing Agreement, Premier Nutrition procures certain packaging materials for Comet that Comet utilizes in the production of RTD shakes for Premier Nutrition. In December 2023, in accordance with the terms of the Co-Packing Agreement, Comet began manufacturing RTD shakes for Premier Nutrition. During both the three and six months ended March 31, 2024, purchases of RTD shakes manufactured by Comet were $1.9 . T here were no purchases of RTD shakes manufactured by Comet during fiscal 2023. In addition, Premier Nutrition incurred $1.0 during the six months ended March 31, 2024 related to start-up costs that are reimbursable to Comet from Premier Nutrition pursuant to the Co-Packing Agreement. No reimbursable start-up costs were incurred by Premier Nutrition during the three months ended March 31, 2024 or the three and six months ended March 31, 2023 . As of March 31, 2024 and September 30, 2023, the Company had current payables with Post of $1.5 and $2.5, respectively, related to RTD shake purchases, MSA fees and reimbursable start-up costs, which were included in “Accounts payable” on the Condensed Consolidated Balance Sheets. Current receivables with Post at b oth March 31, 2024 and September 30, 2023 were immaterial.

Earnings Per Share (Notes)

Earnings Per Share (Notes)	6 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings per share	EARNINGS PER SHARE Basic earnings per share is based on the average number of shares of common stock outstanding during each period. Diluted earnings per share is based on the average number of shares of common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of stock options and restricted stock units using the “treasury stock” method. The following table presents the computation of basic and diluted earnings per share. Three Months Ended Six Months Ended 2024 2023 2024 2023 Net earnings $ 57.2 $ 30.9 $ 101.1 $ 75.1 Weighted-average shares for basic earnings per share 131.0 133.4 131.1 134.1 Effect of dilutive securities: Stock options 0.2 0.1 0.2 0.1 Restricted stock units 0.3 0.2 0.3 0.2 Performance-based restricted stock units 1.5 0.8 1.4 0.4 Weighted-average shares for diluted earnings per share 133.0 134.5 133.0 134.8 Basic earnings per common share $ 0.44 $ 0.23 $ 0.77 $ 0.56 Diluted earnings per common share $ 0.43 $ 0.23 $ 0.76 $ 0.56 The following table presents the securities that have been excluded from the calculation of weighted-average shares for diluted earnings per share as they were anti-dilutive. Three Months Ended Six Months Ended 2024 2023 2024 2023 Restricted stock units — — — 0.1 Performance-based restricted stock units — — — 0.3

Inventories (Notes)

Inventories (Notes)	6 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Inventories	INVENTORIES March 31, September 30, Raw materials and supplies $ 60.2 $ 60.4 Work in process 0.1 0.1 Finished products 133.8 133.8 Inventories $ 194.1 $ 194.3

Property, net (Notes)

Property, net (Notes)	6 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property, net	PROPERTY, NET March 31, September 30, Property, at cost $ 22.0 $ 24.0 Accumulated depreciation (13.5) (15.5) Property, net $ 8.5 $ 8.5

Goodwill (Notes)

Goodwill (Notes)	6 Months Ended
	Mar. 31, 2024
Goodwill [Abstract]
Goodwill	GOODWILL The components of “Goodwill” on the Condensed Consolidated Balance Sheets at both March 31, 2024 and September 30, 2023 are presented in the following table. Goodwill, gross $ 180.7 Accumulated impairment losses (114.8) Goodwill $ 65.9

Intangible Assets, net (Notes)

Intangible Assets, net (Notes)	6 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net	INTANGIBLE ASSETS, NET March 31, 2024 September 30, 2023 Carrying Accumulated Net Carrying Accumulated Net Customer relationships $ 160.7 $ (90.2) $ 70.5 $ 178.4 $ (97.2) $ 81.2 Trademarks and brands 164.5 (84.6) 79.9 194.0 (98.4) 95.6 Other intangible assets 3.1 (3.1) — 3.1 (3.1) — Intangible assets, net $ 328.3 $ (177.9) $ 150.4 $ 375.5 $ (198.7) $ 176.8 In August 2023, the Company approved a plan to discontinue the PowerBar business in North America. In connection with the discontinuance, the Company updated the useful lives of the customer relationships and trademark associated with the PowerBar business in North America to reflect the remaining period in which the Company expects to sell existing PowerBar product inventory in North America. Accelerated amortization of zero and $17.4 was recorded during the three and six months ended March 31, 2024, respectively, resulting from the updated useful lives of the customer relationships and trademark associated with the PowerBar business in North America, which were fully amortized and written off as of March 31, 2024.

Fair Value Measurements (Notes)

Fair Value Measurements (Notes)	6 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair value measurements	FAIR VALUE MEASUREMENTS The Company’s financial assets and liabilities include cash and cash equivalents, receivables and accounts payable for which the carrying value approximates fair value due to their short maturities (less than 12 months). The Company does not record its long-term debt at fair value on the Condensed Consolidated Balance Sheets. The fair value of outstanding borrowings under the Revolving Credit Facility (as defined in Note 11) as of September 30, 2023 approximated its carrying value. Based on market rates, the fair value (Level 2) of the Company’s debt, excluding any borrowings under the Revolving Credit Facility, was $866.6 and $830.0 as of March 31, 2024 and September 30, 2023, respectively. Certain assets and liabilities, including property, goodwill and other intangible assets, are measured at fair value on a non-recurring basis using Level 3 inputs.

Long-Term Debt (Notes)

Long-Term Debt (Notes)	6 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Long-term debt	LONG-TERM DEBT The following table presents the components of “Long-term debt” on the Condensed Consolidated Balance Sheets. March 31, September 30, 7.00% Senior Notes maturing in March 2030 $ 840.0 $ 840.0 Revolving Credit Facility — 25.0 Total principal amount of debt 840.0 865.0 Less: Debt issuance costs, net 7.6 8.2 Long-term debt $ 832.4 $ 856.8 On March 10, 2022, the Company entered into a credit agreement (as amended, the “Credit Agreement”), which provides for a revolving credit facility in an aggregate principal amount of $250.0 (the “Revolving Credit Facility”), with commitments made available to the Company in U.S. Dollars, Euros and United Kingdom (“U.K.”) Pounds Sterling. Letters of credit are available under the Credit Agreement in an aggregate amount of up to $20.0. Any outstanding amounts under the Credit Agreement must be repaid on or before March 10, 2027. Borrowings under the Revolving Credit Facility bear interest at an annual rate equal to: (i) in the case of loans denominated in U.S. Dollars, at the Company’s option, the base rate (as defined in the Credit Agreement) plus a margin which ranges from 2.00% to 2.75% depending on the Company’s secured net leverage ratio (as defined in the Credit Agreement), or the adjusted term SOFR rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; (ii) in the case of loans denominated in Euros, the adjusted Eurodollar rate (as defined in the Credit Agreement) for the applicable interest period plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio; and (iii) in the case of loans denominated in U.K. Pounds Sterling, the adjusted daily simple RFR (as defined in the Credit Agreement) plus a margin which ranges from 3.00% to 3.75% depending on the Company’s secured net leverage ratio. Facility fees on the daily unused amount of commitments under the Revolving Credit Facility will accrue at rates ranging from 0.25% to 0.375% per annum, depending on the Company’s secured net leverage ratio. During the six months ended March 31, 2024 and 2023, the Company borrowed zero and $115.0 under the Revolving Credit Facility, respectively, and repaid $25.0 and $75.0 under the Revolving Credit Facility, respectively. The interest rate on the utilized portion of the Revolving Credit Facility was 8.42% as of September 30, 2023, and there were no amounts outstanding under the Revolving Credit Facility as of March 31, 2024. The available borrowing capacity under the Revolving Credit Facility was $250.0 and $225.0 as of March 31, 2024 and September 30, 2023, respectively, and there were no outstanding letters of credit as of March 31, 2024 or September 30, 2023 . Under the terms of the Credit Agreement, the Company is required to maintain a total net leverage ratio (as defined in the Credit Agreement) not to exceed 6.00:1.00, measured as of the last day of each fiscal quarter. The total net leverage ratio of the Company did not exceed this threshold as of March 31, 2024. The Credit Agreement provides for potential incremental revolving and term facilities at the Company’s request and at the discretion of the lenders or other persons providing such incremental facilities, in each case on terms to be determined, and also permits the Company to incur other secured or unsecured debt, in all cases subject to conditions and limitations as specified in the Credit Agreement. Furthermore, the Credit Agreement provides for customary events of default. Upon the occurrence and during the continuance of an event of default, the maturity of the loans under the Credit Agreement may accelerate and the administrative agent and lenders under the Credit Agreement may exercise other rights and remedies available at law or under the loan documents, including with respect to the collateral securing, and guarantees of, the Company’s obligations under the Credit Agreement. The Company’s obligations under the Credit Agreement are unconditionally guaranteed by its existing and subsequently acquired or organized direct and indirect subsidiaries (other than immaterial subsidiaries, certain excluded subsidiaries and subsidiaries the Company designates as unrestricted subsidiaries) and are secured by security interests in substantially all of the Company’s assets and the assets of its subsidiary guarantors, but excluding, in each case, real property.

Commitments and Contingencies (

Commitments and Contingencies (Notes)	6 Months Ended
	Mar. 31, 2024
Legal Proceedings [Abstract]
Commitments and contingencies	COMMITMENTS AND CONTINGENCIES Legal Proceedings Joint Juice Litigation In March 2013, a complaint was filed on behalf of a putative, nationwide class of consumers against Premier Nutrition in the U.S. District Court for the Northern District of California seeking monetary damages and injunctive relief. The case asserted that some of Premier Nutrition’s advertising claims regarding its Joint Juice line of glucosamine and chondroitin dietary supplement beverages, which it discontinued in the first quarter of fiscal 2023, were false and misleading. In April 2016, the district court certified a California-only class of consumers in this lawsuit (this lawsuit is hereinafter referred to as the “California Federal Class Lawsuit”). In 2016 and 2017, the lead plaintiff’s counsel in the California Federal Class Lawsuit filed ten additional class action complaints in the U.S. District Court for the Northern District of California on behalf of putative classes of consumers under the laws of Connecticut, Florida, Illinois, New Jersey, New Mexico, New York, Maryland, Massachusetts, Michigan and Pennsylvania (the “Related Federal Actions”). These complaints contain factual allegations similar to the California Federal Class Lawsuit, also seeking monetary damages and injunctive relief. The action on behalf of New Jersey consumers was voluntarily dismissed. Trial in the action on behalf of New York consumers was held beginning in May 2022, and the jury delivered its verdict in favor of plaintiff in June 2022. In August 2022, the Court entered a judgment in that case in favor of plaintiff in the amount of $12.9, which includes statutory damages and prejudgment interest. In October 2022, each plaintiff and Premier Nutrition filed Notices of Appeal to the Ninth Circuit, which appeals are pending. The other eight Related Federal Actions remain pending, and the court has certified individual state classes in each of those cases (except New Mexico). In April 2018, the district court dismissed the California Federal Class Lawsuit with prejudice. This dismissal was upheld on appeal by the U.S. Court of Appeals for the Ninth Circuit in 2020, and plaintiff’s petition for an en banc rehearing by the Ninth Circuit was denied. In September 2020, the same lead counsel re-filed the California Federal Class Lawsuit against Premier Nutrition in California Superior Court for the County of Alameda, alleging identical claims and seeking restitution and injunctive relief on behalf of the same putative class of California consumers as the California Federal Class Lawsuit. In March 2023, the Alameda Superior Court granted in part and denied in part Premier Nutrition’s motion for judgment based on res judicata and in May 2023, the Court reaffirmed its ruling. In July 2023, Premier Nutrition filed a petition for writ of mandamus in the California Court of Appeal, which writ was denied in March 2024. In November 2023, the Court certified the case as a class action. Trial is anticipated in calendar year 2024. In January 2019, the same lead counsel filed an additional class action complaint against Premier Nutrition in California Superior Court for the County of Alameda, alleging claims similar to the above actions and seeking monetary damages and injunctive relief on behalf of a putative class of California consumers, beginning after the California Federal Class Lawsuit class period. In July 2020, the court issued an order certifying a statewide class. Premier Nutrition moved for summary judgment on July 7, 2023, which motion remains pending. Trial is anticipated in calendar year 2024. The Company continues to vigorously defend these cases and intends to appeal any adverse judgements and awards of damages. The Company does not believe that the ultimate resolution of these cases will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to this litigation was incurred during the three or six months ended March 31, 2024 or 2023. At both March 31, 2024 and September 30, 2023, the Company had an estimated liability of $21.0 rel ated to these matters that was included in “Other current liabilities” on the Condensed Consolidated Balance Sheets. Protein Products Class Litigation In June 2023, a complaint was filed on behalf of a putative, nationwide class of consumers against the Company and Premier Nutrition in the U.S. District Court for the Northern District of California. The complaint alleges that Premier Nutrition engages in fraud and false advertising (via alleged affirmative representations and omissions) regarding its RTD protein shakes and protein powders by marketing the products as good sources of nutrition and protein when the products contain (or have a material risk of containing) high levels of undisclosed lead (this lawsuit is hereinafter referred to as the “Protein Products Class Lawsuit”). Plaintiffs seek monetary remedies for economic injury (products are allegedly worth less than what was paid for them), as well as injunctive relief. The Protein Products Class Lawsuit alleges that high levels of lead pose serious safety risks, but does not allege that any plaintiff or putative class member suffered personal injuries and does not seek any remedies for personal injuries. The Company and Premier Nutrition filed a motion to dismiss this case in August 2023, which motion is pending. The Company intends to vigorously defend the case, including appealing any adverse judgement or award. The Company does not believe that the ultimate resolution of the Protein Products Class Lawsuit will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to the Protein Products Class Lawsuit was incurred during the three or six months ended March 31, 2024 or 2023. California Proposition 65 Notice re Lead in Protein Products On June 7, 2023, the Fitzgerald Joseph LLP law firm (the same firm that filed the Protein Products Class Lawsuit) issued a 60-Day Notice of Intent to Sue under California’s Safe Water and Toxic Enforcement Act (Proposition 65) for alleged violation of Proposition 65 with respect to lead levels in Premier Nutrition’s RTD protein shakes and protein powders (this matter is hereinafter referred to as the “Protein Products Prop 65 Notice”). Premier Nutrition intends to vigorously defend against the Protein Products Prop 65 Notice. The Company does not believe that the ultimate resolution of the Protein Products Prop 65 Notice will have a material adverse effect on its consolidated financial condition, results of operations or cash flows. Other than legal fees, no expense related to the Protein Products Prop 65 Notice was incurred during the three or six months ended March 31, 2024 or 2023. Other The Company is subject to various other legal proceedings and actions arising in the normal course of business. In the opinion of management, based upon the information presently known, the ultimate liability, if any, arising from such pending legal proceedings, as well as from asserted legal claims and known potential legal claims which are likely to be asserted, taking into account established accruals for estimated liabilities (if any), are not expected to be material individually or in the aggregate to the consolidated financial condition, results of operations or cash flows of the Company. In addition, although it is difficult to estimate the potential financial impact of actions regarding expenditures for compliance with regulatory matters, in the opinion of management, based upon the information currently available, the ultimate liability arising from such compliance matters is not expected to be material to the consolidated financial condition, results of operations or cash flows of the Company.

Stockholders' Equity (Notes)

Stockholders' Equity (Notes)	6 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	STOCKHOLDERS’ DEFICIT The following table summarizes the Company’s repurchases of its common stock . Three Months Ended Six Months Ended 2024 2023 2024 2023 Shares repurchased 0.4 0.9 0.6 2.7 Average price per share (a) $ 56.46 $ 29.74 $ 52.28 $ 25.52 Total share repurchase cost (b) $ 23.1 $ 27.6 $ 32.5 $ 68.8 (a) Average price per share excludes accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table. (b) “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2024 excluded $1.5 of repurchases of common stock that did not settle until April 2024 and $0.2 of accrued excise tax that had not been paid as of March 31, 2024. “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2023 excluded $0.3 of accrued excise tax that had not been paid as of March 31, 2023.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2024
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		OTHER INFORMATION. Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements During the three months ended March 31, 2024, no director or “officer,” as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Mar. 31, 2024
Revenues [Abstract]
Disaggregation of revenues	Three Months Ended Six Months Ended 2024 2023 2024 2023 Shakes and other beverages $ 397.9 $ 299.9 $ 748.1 $ 596.9 Powders 84.1 73.8 153.8 129.9 Other 12.6 11.9 23.1 21.5 Net Sales $ 494.6 $ 385.6 $ 925.0 $ 748.3

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Computation of basic and diluted earnings per share	Three Months Ended Six Months Ended 2024 2023 2024 2023 Net earnings $ 57.2 $ 30.9 $ 101.1 $ 75.1 Weighted-average shares for basic earnings per share 131.0 133.4 131.1 134.1 Effect of dilutive securities: Stock options 0.2 0.1 0.2 0.1 Restricted stock units 0.3 0.2 0.3 0.2 Performance-based restricted stock units 1.5 0.8 1.4 0.4 Weighted-average shares for diluted earnings per share 133.0 134.5 133.0 134.8 Basic earnings per common share $ 0.44 $ 0.23 $ 0.77 $ 0.56 Diluted earnings per common share $ 0.43 $ 0.23 $ 0.76 $ 0.56
Antidilutive securities excluded from computation of earnings per share	Three Months Ended Six Months Ended 2024 2023 2024 2023 Restricted stock units — — — 0.1 Performance-based restricted stock units — — — 0.3

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Mar. 31, 2024
Inventory [Abstract]
Inventories	March 31, September 30, Raw materials and supplies $ 60.2 $ 60.4 Work in process 0.1 0.1 Finished products 133.8 133.8 Inventories $ 194.1 $ 194.3

Property, net (Tables)

Property, net (Tables)	6 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property, net	March 31, September 30, Property, at cost $ 22.0 $ 24.0 Accumulated depreciation (13.5) (15.5) Property, net $ 8.5 $ 8.5

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Mar. 31, 2024
Goodwill [Abstract]
Carrying amount of goodwill	Goodwill, gross $ 180.7 Accumulated impairment losses (114.8) Goodwill $ 65.9

Intangible Assets, net (Tables)

Intangible Assets, net (Tables)	6 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Total intangible assets	March 31, 2024 September 30, 2023 Carrying Accumulated Net Carrying Accumulated Net Customer relationships $ 160.7 $ (90.2) $ 70.5 $ 178.4 $ (97.2) $ 81.2 Trademarks and brands 164.5 (84.6) 79.9 194.0 (98.4) 95.6 Other intangible assets 3.1 (3.1) — 3.1 (3.1) — Intangible assets, net $ 328.3 $ (177.9) $ 150.4 $ 375.5 $ (198.7) $ 176.8

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Long-term Debt	March 31, September 30, 7.00% Senior Notes maturing in March 2030 $ 840.0 $ 840.0 Revolving Credit Facility — 25.0 Total principal amount of debt 840.0 865.0 Less: Debt issuance costs, net 7.6 8.2 Long-term debt $ 832.4 $ 856.8

Stockholders' Equity (Table)

Stockholders' Equity (Table)	6 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Class of Treasury Stock	Three Months Ended Six Months Ended 2024 2023 2024 2023 Shares repurchased 0.4 0.9 0.6 2.7 Average price per share (a) $ 56.46 $ 29.74 $ 52.28 $ 25.52 Total share repurchase cost (b) $ 23.1 $ 27.6 $ 32.5 $ 68.8 (a) Average price per share excludes accrued excise tax and broker’s commissions, which are included in “Total share repurchase cost” within this table. (b) “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2024 excluded $1.5 of repurchases of common stock that did not settle until April 2024 and $0.2 of accrued excise tax that had not been paid as of March 31, 2024. “Purchases of treasury stock” in the Condensed Consolidated Statements of Cash Flows for the six months ended March 31, 2023 excluded $0.3 of accrued excise tax that had not been paid as of March 31, 2023.

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue
Net Sales	$ 494.6	$ 385.6	$ 925	$ 748.3
Shakes and other beverages
Disaggregation of Revenue
Net Sales	397.9	299.9	748.1	596.9
Powders
Disaggregation of Revenue
Net Sales	84.1	73.8	153.8	129.9
Other
Disaggregation of Revenue
Net Sales	$ 12.6	$ 11.9	$ 23.1	$ 21.5

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Related Party Transactions [Abstract]
Master Service Agreement Fees, Related Party	$ 0.8	$ 1	$ 1.7	$ 2.3
Purchases from related party	1.9		1.9
Start-up costs reimbursable to related party			1
Accounts Payable, related party	$ 1.5		$ 1.5		$ 2.5

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Net earnings	$ 57.2	$ 30.9	$ 101.1	$ 75.1
Weighted Average shares of Common Stock Outstanding, basic (in shares)	131	133.4	131.1	134.1
Weighted-Average shares of Common Stock Outstanding, diluted (in shares)	133	134.5	133	134.8
Earnings per share of Common Stock, basic (in USD per share)	$ 0.44	$ 0.23	$ 0.77	$ 0.56
Earnings per share of Common Stock, diluted (in USD per share)	$ 0.43	$ 0.23	$ 0.76	$ 0.56
Stock options
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	0.2	0.1	0.2	0.1
Restricted Stock Units (RSUs)
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	0.3	0.2	0.3	0.2
Antidilutive securities excluded from computation of earnings per share, amount	0	0	0	0.1
Performance-Based Restricted Stock Units
Earnings Per Share, Diluted, by Common Class, Including Two Class Method
Dilutive restricted stock units, (in shares)	1.5	0.8	1.4	0.4
Antidilutive securities excluded from computation of earnings per share, amount	0	0	0	0.3

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Inventory [Abstract]
Raw materials and supplies	$ 60.2	$ 60.4
Work in process	0.1	0.1
Finished products	133.8	133.8
Inventories	$ 194.1	$ 194.3

Property, net (Details)

Property, net (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Property, at cost	$ 22	$ 24
Accumulated depreciation	(13.5)	(15.5)
Property, net	$ 8.5	$ 8.5

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Goodwill [Abstract]
Goodwill, gross	$ 180.7	$ 180.7
Accumulated impairment losses	(114.8)	(114.8)
Goodwill	$ 65.9	$ 65.9

Intangible Assets, net (Details

Intangible Assets, net (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Sep. 30, 2023
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	$ 328.3	$ 328.3	$ 375.5
Finite-lived intangible assets, accumulated amortization	(177.9)	(177.9)	(198.7)
Finite-lived intangible assets, net	150.4	150.4	176.8
Accelerated amortization	17.4	17.4
Customer relationships
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	160.7	160.7	178.4
Finite-lived intangible assets, accumulated amortization	(90.2)	(90.2)	(97.2)
Finite-lived intangible assets, net	70.5	70.5	81.2
Trademarks and brands
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	164.5	164.5	194
Finite-lived intangible assets, accumulated amortization	(84.6)	(84.6)	(98.4)
Finite-lived intangible assets, net	79.9	79.9	95.6
Other intangible assets
Finite-Lived Intangible Assets
Finite-lived intangible assets, gross	3.1	3.1	3.1
Finite-lived intangible assets, accumulated amortization	(3.1)	(3.1)	(3.1)
Finite-lived intangible assets, net	$ 0	$ 0	$ 0

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Millions	Mar. 31, 2024	Sep. 30, 2023
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Debt, fair value	$ 866.6	$ 830

Long-Term Debt (Details)

Long-Term Debt (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Sep. 30, 2023
Debt Instrument
Long-term and short-term debt, combined amount	$ 840		$ 865
Unamortized Debt Issuance Expense	(7.6)		(8.2)
Long-term debt	832.4		856.8
7.00% Senior Notes Maturing in March 2030
Debt Instrument
Long-term debt, gross	840		840
Revolving Credit Facility
Debt Instrument
Long-term debt, gross	0		25
Maximum borrowing capacity on line of credit	250
Proceeds from borrowing under line of credit	0	$ 115
Repayments of lines of credit	25	$ 75
Remaining borrowing capacity on line of credit	250		225
Letters of credit outstanding, amount	0		$ 0
Letter of Credit
Debt Instrument
Maximum borrowing capacity on line of credit	$ 20

Long-Term Debt - Rates and Rati

Long-Term Debt - Rates and Ratios (Details)	6 Months Ended
	Mar. 31, 2024	Sep. 30, 2023
Debt Instrument
Debt covenant, leverage ratio	6
Revolving Credit Facility | Minimum
Debt Instrument
Unused capacity on line of credit commitment fee percentage	0.25%
Revolving Credit Facility | Maximum
Debt Instrument
Unused capacity on line of credit commitment fee percentage	0.375%
Revolving Credit Facility, Interest Rate on Utilized Portion		8.42%
Revolving Credit Facility | Base Rate | Minimum
Debt Instrument
Basis spread on variable interest rate	2%
Revolving Credit Facility | Base Rate | Maximum
Debt Instrument
Basis spread on variable interest rate	2.75%
Revolving Credit Facility | SOFR Rate | Minimum
Debt Instrument
Basis spread on variable interest rate	3%
Revolving Credit Facility | SOFR Rate | Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%
Revolving Credit Facility | Eurodollar | Minimum
Debt Instrument
Basis spread on variable interest rate	3%
Revolving Credit Facility | Eurodollar | Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%
Revolving Credit Facility | BritishPound Rate | Minimum
Debt Instrument
Basis spread on variable interest rate	3%
Revolving Credit Facility | BritishPound Rate | Maximum
Debt Instrument
Basis spread on variable interest rate	3.75%

Commitments and Contingencies_2

Commitments and Contingencies (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Mar. 31, 2024	Sep. 30, 2023
Loss Contingencies
Litigation Settlement, Amount Awarded to Other Party	$ 12.9
Other current liabilities
Loss Contingencies
Estimated litigation liability, current		$ 21	$ 21

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Class of Stock [Line Items]
Total share repurchase cost (b)			$ 30.8	$ 68.5
BellRing Common Stock | Common Stock
Class of Stock [Line Items]
Shares repurchased	0.4	0.9	0.6	2.7
Average price per share	$ 56.46	$ 29.74	$ 52.28	$ 25.52
Total share repurchase cost (b)	$ 23.1	$ 27.6	$ 32.5	$ 68.8
Payments of accrued repurchases of common stock	1.5		1.5
Excise Tax Payable, Current	$ 0.2		$ 0.2